Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
-13.3K
-
Total reported value, excl. options
-
$394M
-
Value change
-
-$146K
-
Put/Call ratio
-
0.41
-
Number of sells
-
-1
-
Price
-
$12.41
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q4 2013
109 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q4 2013.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
of 58.9M outstanding shares and own 53.98% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4.79M shares), FMR LLC (3.49M shares), Palo Alto Investors, LLC (3.24M shares), BlackRock Fund Advisors (1.28M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.21M shares), Invesco Ltd. (1.13M shares), BlackRock Institutional Trust Company, N.A. (1.04M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.04M shares), ORBIMED ADVISORS LLC (990K shares), and VANGUARD GROUP INC (944K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.